Vaccination and Immunization

>

Latest News

Specific groups with chronic conditions who could most benefit from RSV prophylaxis | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.
Specific groups with chronic conditions who could most benefit from RSV prophylaxis

July 8th 2025

A newly-published study identified specific groups of higher-risk children that could benefit most from monoclonal antibodies.

ACIP updates: Committee votes 5-2 to recommend clesrovimab to protect against RSV | Image Credit: © JJHVEPhoto - © JHVEPhoto - stock.adobe.com.
ACIP updates: Committee recommends clesrovimab for RSV, reaffirms routine influenza vaccination

June 26th 2025

ACIP: New members meeting June 26,26; AAP liaisons not participating | Image Credit: © weyo - © weyo - stock.adobe.com.
ACIP: New members meeting June 25-26; AAP liaisons not participating

June 25th 2025

Donna Hallas
PNP Perspective: Focus on the positive outcomes of accepting vaccines

June 25th 2025

Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years | Image Credit: © ImageKing - © ImageKing - stock.adobe.com.
Bavarian Nordic initiates trial of chikungunya vaccine in children aged 2-11 years

June 13th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.